{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T15:34:33Z","timestamp":1765812873794,"version":"3.48.0"},"reference-count":26,"publisher":"The Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hypercalcemia of malignancy is a recognized complication of diffuse large B-cell lymphoma (DLBCL) and is associated with decreased survival time and more advanced disease. We present a case of DLBCL complicated by severe refractory calcitriol-mediated hypercalcemia and renal failure that was unresponsive to conventional treatments. Treatment with glucocorticoids and concurrent antiresorptive therapy was also ineffective. Ultimately, hemodialysis was necessary to treat the patient's hypercalcemia and tenuous volume status. This case demonstrates that calcitriol-mediated hypercalcemia of malignancy in DLBCL may be unresponsive to standard hypercalcemia interventions, and it supports the utility of hemodialysis as a method of treating hypercalcemia, especially in patients with renal impairment.<\/jats:p>","DOI":"10.1210\/jcemcr\/luaf274","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:31:15Z","timestamp":1761222675000},"source":"Crossref","is-referenced-by-count":0,"title":["Severe Refractory Calcitriol-Mediated Hypercalcemia in Diffuse Large B-Cell Lymphoma Treated With Hemodialysis"],"prefix":"10.1210","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2241-0855","authenticated-orcid":false,"given":"Julius","family":"Wu","sequence":"first","affiliation":[{"name":"College of Medicine, SUNY Downstate Health Sciences University , Brooklyn, NY 11203 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gitanjali","family":"Reddy","sequence":"additional","affiliation":[{"name":"College of Medicine, SUNY Downstate Health Sciences University , Brooklyn, NY 11203 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhanna","family":"Zavgorodneva","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes, and Metabolism, SUNY Downstate Health Sciences University , Brooklyn, NY 11203 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisel","family":"Hope","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes, and Metabolism, SUNY Downstate Health Sciences University , Brooklyn, NY 11203 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"issue":"4","key":"2025121510320747800_luaf274-B1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMcp042806","article-title":"Hypercalcemia associated with cancer","volume":"352","author":"Stewart","year":"2005","journal-title":"N Engl J Med"},{"issue":"15","key":"2025121510320747800_luaf274-B2","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMcp2113128","article-title":"Cancer-associated hypercalcemia","volume":"386","author":"Guise","year":"2022","journal-title":"N Engl J Med"},{"issue":"5","key":"2025121510320747800_luaf274-B3","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1210\/jc.2014-4250","article-title":"PTHrP-mediated hypercalcemia: causes and survival in 138 patients","volume":"100","author":"Donovan","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025121510320747800_luaf274-B4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41572-020-00216-3","article-title":"Bone metastases","volume":"6","author":"Coleman","year":"2020","journal-title":"Nat Rev Dis Primer"},{"issue":"5","key":"2025121510320747800_luaf274-B5","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood.V82.5.1383.1383","article-title":"Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin's disease and non-Hodgkin's lymphomas","volume":"82","author":"Seymour","year":"1993","journal-title":"Blood"},{"issue":"6","key":"2025121510320747800_luaf274-B6","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/archsurg.1980.01380060012004","article-title":"Incidence of hypercalcemia and malignant neoplasm","volume":"115","author":"Burt","year":"1980","journal-title":"Arch Surg"},{"issue":"8","key":"2025121510320747800_luaf274-B7","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/jcp.55.8.637-a","article-title":"Incidence and prognostic significance of hypercalcaemia in B-cell non-Hodgkin's lymphoma","volume":"55","author":"Majumdar","year":"2002","journal-title":"J Clin Pathol"},{"issue":"10","key":"2025121510320747800_luaf274-B8","first-page":"332","article-title":"[Hypercalcemia in non-Hodgkin lymphoma]","volume":"115","author":"Baechler","year":"1985","journal-title":"Schweiz Med Wochenschr"},{"issue":"12","key":"2025121510320747800_luaf274-B9","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1080\/10428194.2019.1620946","article-title":"Prevalence and clinical significance of hypercalcemia at diagnosis in diffuse large B-cell lymphoma","volume":"60","author":"Abadi","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"2025121510320747800_luaf274-B10","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/hon.2735","article-title":"Hypercalcemia at diagnosis of diffuse large B-cell lymphoma is not uncommon and is associated with high-risk features and a short diagnosis-to-treatment interval","volume":"38","author":"Gauchy","year":"2020","journal-title":"Hematol Oncol"},{"issue":"7","key":"2025121510320747800_luaf274-B11","doi-asserted-by":"crossref","first-page":"499","DOI":"10.7326\/0003-4819-112-7-499","article-title":"Cancer-associated hypercalcemia: morbidity and mortality","volume":"112","author":"Ralston","year":"2008","journal-title":"Ann Intern Med"},{"issue":"9","key":"2025121510320747800_luaf274-B12","doi-asserted-by":"crossref","first-page":"633","DOI":"10.7326\/0003-4819-121-9-199411010-00001","article-title":"Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphoma","volume":"121","author":"Seymour","year":"1994","journal-title":"Ann Intern Med"},{"issue":"12","key":"2025121510320747800_luaf274-B13","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1007\/s00198-021-06054-7","article-title":"Hypercalcemia in non-Hodgkin's lymphoma due to cosecretion of PTHrP and 1,25-dihydroxyvitamin D","volume":"32","author":"Gonciulea","year":"2021","journal-title":"Osteoporos Int"},{"issue":"8","key":"2025121510320747800_luaf274-B14","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2169\/internalmedicine.31.968","article-title":"Parathyroid hormone-related protein as a cause of hypercalcemia in a B-cell type malignant lymphoma","volume":"31","author":"Wada","year":"1992","journal-title":"Intern Med"},{"issue":"3","key":"2025121510320747800_luaf274-B15","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1046\/j.1365-2141.1996.d01-1819.x","article-title":"Parathyroid hormone-related protein in hypercalcaemia associated with haematological malignancy","volume":"94","author":"Firkin","year":"1996","journal-title":"Br J Haematol"},{"issue":"2","key":"2025121510320747800_luaf274-B16","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/j.clml.2017.12.006","article-title":"Mechanisms of hypercalcemia in non-Hodgkin lymphoma and associated outcomes: a retrospective review","volume":"18","author":"Shallis","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"4","key":"2025121510320747800_luaf274-B17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.7326\/0003-4819-149-4-200808190-00007","article-title":"Narrative review: furosemide for hypercalcemia: an unproven yet common practice","volume":"149","author":"LeGrand","year":"2008","journal-title":"Ann Intern Med"},{"issue":"1","key":"2025121510320747800_luaf274-B18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bone.2010.12.024","article-title":"The kidney and bisphosphonates","volume":"49","author":"Miller","year":"2011","journal-title":"Bone"},{"issue":"6","key":"2025121510320747800_luaf274-B19","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2165\/00003495-200161060-00010","article-title":"Zoledronic acid","volume":"61","author":"Cheer","year":"2001","journal-title":"Drugs"},{"issue":"10","key":"2025121510320747800_luaf274-B20","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.2215\/CJN.02470312","article-title":"Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia","volume":"7","author":"Rosner","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"2025121510320747800_luaf274-B21","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1210\/clinem\/dgac621","article-title":"Treatment of hypercalcemia of malignancy in adults: an endocrine society clinical practice guideline","volume":"108","author":"El-Hajj Fuleihan","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025121510320747800_luaf274-B22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/BF01720717","article-title":"Calcium free hemodialysis: experience in the treatment of 33 patients with severe hypercalcemia","volume":"22","author":"Camus","year":"1996","journal-title":"Intensive Care Med"},{"issue":"6","key":"2025121510320747800_luaf274-B23","first-page":"285","article-title":"Role of dialysis in the treatment of severe hypercalcemia: report of two cases successfully treated with hemodialysis and review of the literature","volume":"12","author":"Cardella","year":"1979","journal-title":"Clin Nephrol"},{"issue":"4","key":"2025121510320747800_luaf274-B24","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/MAT.0b013e31817dc3be","article-title":"Treatment of severe hypercalcemia using continuous renal replacement therapy with regional citrate anticoagulation","volume":"54","author":"Kindgen-Milles","year":"2008","journal-title":"ASAIO J"},{"issue":"3","key":"2025121510320747800_luaf274-B25","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1159\/000188907","article-title":"Calcium-free hemodialysis for the management of hypercalcemia","volume":"72","author":"Koo","year":"1996","journal-title":"Nephron"},{"issue":"3","key":"2025121510320747800_luaf274-B26","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s001340050562","article-title":"Continuous venovenous hemodiafiltration (CWHDF) with citrate anticoagulation in the treatment of a patient with acute renal failure, hypercalcemia, and thrombocytopenia","volume":"24","author":"\u0160r\u00e1mek","year":"1998","journal-title":"Intensive Care Med"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/1\/luaf274\/65695710\/luaf274.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/1\/luaf274\/65695710\/luaf274.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T15:32:14Z","timestamp":1765812734000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luaf274\/8363400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,3]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luaf274","relation":{},"ISSN":["2755-1520"],"issn-type":[{"type":"electronic","value":"2755-1520"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,12,3]]},"article-number":"luaf274"}}